How is Cognizant preparing its clients for the next wave of technological innovation?

Latest Quarter | Q1 2025 · Press Release · Presentation · Infographic · Webcast · Transcript · Form 10-Q(opens in new window) · All Quarters Investor Toolkit ... CTSH means that all non-originating materials used in the production of the good have undergone a change in tariff classification at the 6-digit level. Jan 28, 2025 ... Stocks With Rising Relative Strength: Cognizant Tech Solutions ... Cognizant Tech Solutions (CTSH) had its Relative Strength (RS) Rating upgraded ... Cognizant Technology Solutions Stock Analysis: Historical quarterly revenues per share for Cognizant Technology Solutions and historical quarterly revenue ... As of today, Cognizant Technology Solutions's weighted average cost of capital is 10.03%%. Cognizant Technology Solutions's ROIC % is 14.27% (calculated using ... This study shows that the risk variant rs3825932 in the candidate gene cathepsin H (CTSH) predicts β-cell function in both model systems and human T1D, ... Cognizant Technology Solutions Corp holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it ... Based on short-term price targets offered by 19 analysts, the average price target for Cognizant comes to $90.74. The forecasts range from a low of $80.00 to a ... Objective-To determine effect of time of sample collection on serum thyrotropin (canine thyroid-stimu- lating hormone [cTSH]) concentrations in euthyroid. Jun 15, 2016 ... ... cTSH), occur in about 25 percent of hypothyroid dogs. False-positive results (elevated cTSH), occur in about 10 percent of dogs with NTI and ...